MetaCap

Monopar Therapeutics Statistics

NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

69.00-1.29 (-1.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Monopar Therapeutics by the numbers

Monopar Therapeutics has a market capitalization of $467.6 million based on 6.78M shares outstanding. With trailing EPS of $-2.44, Monopar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.9% below its 50-day average and 11.0% below its 200-day average.

Average daily trading volume is 151.83K shares, or about $10.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MNPR valuation vs. peer median

MNPR compared with the median of 8 peer companies
MetricMNPRPeer medianDifference
Market cap$467.60M$461.00M+1%
Avg. volume151.83K308.58K-51%

Peer median across 8 companies: EVO, RZLT, HELP, BLSM, GYRE, NGNE, ASMB, STTK.

Valuation

Price and trading

Previous close
70.29
Open
68.50
Day range
67.36 – 69.86
52-week range
50.07 – 124.82
52-week change
-24.64%
Beta
—
Volume
132.61K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
467.60M
Forward Pe
-20.39
Eps
-2.44
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
124.82
Week52 Low
50.07
Avg Volume
151.83K
Shares Outstanding
6.78M
Ma50
78.36
Ma200
77.49
Earnings Date
Nov 12, 2026
Pct From52w High
-44.72%
Pct From52w Low
37.81%

Related